2014
DOI: 10.1038/icb.2014.49
|View full text |Cite
|
Sign up to set email alerts
|

Distinct spatial distribution of microglia and macrophages following mesenchymal stem cell implantation in mouse brain

Abstract: Although implantation of cellular material in the central nervous system (CNS) is a key direction in CNS regenerative medicine, this approach is currently limited by the occurrence of strong endogenous immune cell responses. In a model of mesenchymal stem cell (MSC) grafting in the CNS of immune-competent mice, we previously described that MSC grafts become highly surrounded and invaded by Iba1 þ myeloid cells (microglia and/or macrophages). Here, following grafting of blue fluorescent protein (BFP)-expressing… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
45
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
8

Relationship

6
2

Authors

Journals

citations
Cited by 30 publications
(48 citation statements)
references
References 39 publications
3
45
0
Order By: Relevance
“…Interestingly, however, the early injection of negative control of miR at day 2 after ischemia only gave rise to a smaller M1 marker expression by Iba-1 + cells in comparison to the stroke only group. In support of our observation, Le Blon and colleagues observed fewer MHCII + expressions by Iba-1 + cells, as M1 associated marker, in sham implanted group in a mouse model of mesenchymal stem cell implantation (Le Blon et al 2014). …”
Section: Discussionsupporting
confidence: 88%
“…Interestingly, however, the early injection of negative control of miR at day 2 after ischemia only gave rise to a smaller M1 marker expression by Iba-1 + cells in comparison to the stroke only group. In support of our observation, Le Blon and colleagues observed fewer MHCII + expressions by Iba-1 + cells, as M1 associated marker, in sham implanted group in a mouse model of mesenchymal stem cell implantation (Le Blon et al 2014). …”
Section: Discussionsupporting
confidence: 88%
“…In this study, we used a previously established and characterised C57BL/6 mouse BM-derived MSC line (further named as parental MSC) [20] and a derivative thereof, genetically engineered to express the blue fluorescent protein (further named as blue fluorescent protein (BFP)-MSC) [13]. For expansion, both MSC lines were cultured in standard cell culture plasticware (well plates and/or culture flasks) in ‘complete expansion medium’ (CEM) [21] consisting of Iscove’s modified Dulbecco’s medium (IMDM; Lonza) supplemented with 8% fetal bovine serum (FBS; Invitrogen), 8% horse serum (HS; Invitrogen), 200U/ml + 100 μg/ml penicillin/streptomycin (Invitrogen) and 1 μg/ml amphotericin B (Invitrogen).…”
Section: Methodsmentioning
confidence: 99%
“…MSC cultures were split 1:5 twice a week using 0.05% trypsin-EDTA (Invitrogen) for cell detachment. Both the parental MSC line and the BFP-MSC line were transduced with the pCHMWS-IL13-IRES-Pac LVv, according to previously optimised procedures [13, 21]. Following puromycin selection, the resulting engineered MSC lines were further named as IL13-MSC and IL13/BFP-MSC.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…74,75 Recently, it has become clear that MSCs also regulate the function and activation of macrophages. [76][77][78][79] There is a large body of evidence demonstrating that the effects of MSCs on macrophages are critical for inflammatory response and tissue repair after SCI. [80][81][82][83][84] Nakajima et al observed that BM-MSCs altered macrophages into anti-inflammatory M2 and beneficially modulated the immune system.…”
mentioning
confidence: 99%